IL-1β and IL-18 seem to contribute to the pathophysiology of MS, as they are upregulated together with caspase-1 in peripheral blood mononuclear cells (PBMCs) and the cerebrospinal fluid (CSF) of MS patients (216, 217). This evidence concerns the gene IL18 and myeloid sarcoma.